Pfizer Inc. PFE
$27.54
-1.85%
at last close
Analyst Consensus
- Consensus Rating
- Hold (6 Buy · 8 Hold · 1 Sell)
- Average Price Target
- $30.33
- Implied Upside
- +10.1%
- Price Target Range
- $25.00 – $35.00
- Analysts (12 mo)
- 15
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-06 | Freedom BrokerIlya Zubkov |
Maintains | Buy | $33 → $34 |
| 2026-11-05 | GuggenheimVamil Divan |
Maintains | Buy | $31 → $33 |
| 2026-11-04 | UBSMichael Yee |
Maintains | Neutral | $27 → $30 |
| 2026-11-04 | ScotiabankLouise Chen |
Maintains | Sector outperform | $33 → $35 |
| 2026-11-04 | CitigroupGeoff Meacham |
Maintains | Neutral | $27 → $30 |
| 2026-11-04 | RBC CapitalTrung Huynh |
Maintains | Sector perform | $25 → $28 |
| 2026-10-09 | JP MorganChris Schott |
Maintains | Neutral | $28 → $30 |
| 2026-10-08 | Cantor FitzgeraldCarter Gould |
Maintains | Neutral | $27 → $28 |
| 2026-10-06 | ScotiabankLouise Chen |
Maintains | Sector outperform | $30 → $33 |
| 2026-09-10 | HSBCRajesh Kumar |
Maintains | Hold | $28 → $30 |
| 2026-08-07 | GuggenheimVamil Divan |
Maintains | Buy | $35 → $31 |
| 2026-07-13 | BMO CapitalEvan David Seigerman |
Maintains | Outperform | $34 → $30 |
| 2026-07-13 | GuggenheimVamil Divan |
Maintains | Buy | $36 → $35 |
| 2026-07-10 | B of A SecuritiesJason Gerberry |
Maintains | Neutral | $27 → $26 |
| 2026-07-08 | JP MorganChris Schott |
Maintains | Neutral | $30 → $28 |
| 2026-07-06 | Cantor FitzgeraldCarter Gould |
Reiterates | Neutral | $27 |
| 2026-07-06 | HSBCRajesh Kumar |
Downgrades | Buy → Hold | $32 → $28 |
| 2026-06-10 | RBC CapitalTrung Huynh |
Upgrades | Underperform → Sector perform | $25 |
| 2026-04-29 | CitigroupGeoff Meacham |
Maintains | Neutral | $26 → $27 |
| 2026-04-20 | RBC CapitalTrung Huynh |
Reiterates | Underperform | $25 |
| 2026-04-16 | CICCJin Zhang |
Initiates coverage on | Outperform | $33 |
| 2026-04-13 | UBSMichael Yee |
Maintains | Neutral | $25 → $27 |
| 2026-04-10 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $27 → $28 |
| 2026-04-09 | B of A SecuritiesJason Gerberry |
Maintains | Neutral | $27 → $26 |
| 2026-03-24 | GuggenheimVamil Divan |
Maintains | Buy | $35 → $36 |
| 2026-03-17 | HSBCRajesh Kumar |
Maintains | Buy | $29 → $32 |
| 2026-03-02 | Argus ResearchDavid Toung |
Upgrades | Hold → Buy | $35 |
| 2026-02-25 | RBC CapitalTrung Huynh |
Initiates coverage on | Underperform | $25 |
| 2026-02-20 | BarclaysEmily Field |
Initiates coverage on | Underweight | $25 |
| 2026-02-09 | Freedom BrokerIlya Zubkov |
Maintains | Buy | $35 → $33 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $27.54
- Market Cap
- $159.94 billion
- 52-Week Range
- $23.62 – $31.44
- Average Volume
- 34.09 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
